GE Healthcare Announces Preliminary Phase 3 Results for Flutemetamol - MarketWatch (press release)

Find a Pathologist | Pathologist Directory | Pathology Resources Online

Provider Log In | Sign Up and Get Listed Today!

News

Medicine News » Pathology News » GE Healthcare Announces Preliminary Phase 3 Results for Flutemetamol - MarketWatch (press release)

GE Healthcare Announces Preliminary Phase 3 Results for Flutemetamol - MarketWatch (press release)

Posted on April 11^th, 2012, 9:50 am

GE Healthcare Announces Preliminary Phase 3 Results for Flutemetamol
MarketWatch (press release)
The results from these studies are quite encouraging in demonstrating the potential of flutemetamol in that regard,â said Carl Sadowsky, MD, Clinical Professor of Neurology at Nova Southeastern University Ft. Lauderdale, FL.

and more »

...

print this page email this page

Live Pathology

Find a Pathologist

Questions and Answers

Pathology News

Pathology

© Copyright 2009-12 LiveWebDoc.com All Rights Reserved.
Disclaimer: The material on this site is for informational purposes only and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Use at your own risk.